-transparent.png){kind=logo}
Two monoclonal antibodies, HH8 and HH9, have been established after immunization of mice with galactosyl-A glycolipid antigen having the terminal structure, Gal beta 1----3GalNAc alpha 1----3[Fuc alpha 1----2]Gal beta 1----R, which is the precursor for type 3 chain A (repetitive A) and type 3 chain H (A-associated H). Both antibodies react strongly and specifically with galactosyl-A, but HH8 (IgM) showed strong hemagglutination of blood group A1, A2, O and B erythrocytes after sialidase treatment, while HH9 (IgG1) did not react with human erythrocytes even after sialidase treatment. HH8 and anti-T antibody, but not HH9, reacted with glycophorin A after sialidase treatment. The reactivity of HH8 with glycophorin A was abolished by beta-galactosidase and was inhibited by liposomes containing galactosyl-A, but not other glycolipids. In addition, anti-T antibody and peanut lectin reacted specifically with galactosyl-A glycolipids. These findings indicate that HH8 recognizes the terminal disaccharide Gal beta 1----3GalNAc alpha 1----R, which is the same sequence as the classically known Thomsen-Friedenreich antigen (T-antigen), whereas HH9 does not cross-react with T-antigen but recognizes the entire galactosyl-A structure. The T-antigen was also demonstrated by immunohistology with HH8 after neuraminidase treatment in a subset of cells in stratified epithelium.
H Clausen, and
M Stroud, and
J Parker, and
G Springer, and
S Hakomori
January 1997,
International journal of cancer,
H Clausen, and
M Stroud, and
J Parker, and
G Springer, and
S Hakomori
November 1982,
Journal of immunology (Baltimore, Md. : 1950),
H Clausen, and
M Stroud, and
J Parker, and
G Springer, and
S Hakomori
August 1990,
Cancer research,
H Clausen, and
M Stroud, and
J Parker, and
G Springer, and
S Hakomori
January 2003,
Advances in experimental medicine and biology,
H Clausen, and
M Stroud, and
J Parker, and
G Springer, and
S Hakomori
December 1981,
The Journal of biological chemistry,
H Clausen, and
M Stroud, and
J Parker, and
G Springer, and
S Hakomori
January 1989,
Cancer research,
H Clausen, and
M Stroud, and
J Parker, and
G Springer, and
S Hakomori
February 1995,
Hybridoma,
H Clausen, and
M Stroud, and
J Parker, and
G Springer, and
S Hakomori
January 1999,
Acta oncologica (Stockholm, Sweden),
H Clausen, and
M Stroud, and
J Parker, and
G Springer, and
S Hakomori
April 1986,
Cancer research,
H Clausen, and
M Stroud, and
J Parker, and
G Springer, and
S Hakomori
February 1988,
Hinyokika kiyo. Acta urologica Japonica,
